Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Sep 2009):

No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation.

Full Abstract

PURPOSE: The purpose of the study was to assess the impact of age on the pharmacokinetics of immunosuppressive drugs. METHODS: One hundred and ten renal transplant recipients, including 12 elderly patients over 60 years of age, 57 middle-aged patients between 40 and 59 years and 41 young adult patients 20 to 39 years of age were studied. To evaluate dose-adjusted pharmacokinetics and cytochrome P450 (CYP) 3A5 pharmacogenetics, the concentrations of tacrolimus, mycophenolic acid (MPA), MPA glucuronide (MPAG) and prednisolone were measured at 1 month post-transplantation. RESULTS: There were no differences in dose (D) and body weight (BW)-adjusted pharmacokinetic parameters of tacrolimus among the three groups. D/BW-adjusted C(max), C(0) and AUC(0-12) values of tacrolimus were significantly greater in patients with the CYP3A5*3/*3 genotype than in those with the CYP3A5*1 allele in young and middle-aged patients as previously reported, but not in the elderly. There were no significant differences in the D-adjusted pharmacokinetics of prednisolone and MPA among the three groups. CONCLUSION: The aging process itself may have a small effect on the pharmacokinetics of tacrolimus, MPA, or prednisolone. However, a larger number of subjects need to be studied to confirm the impact of age on the CYP3A5 pharmacogenetics of tacrolimus in the elderly.

 

Author information

Author/s: Miura, Masatomo (M); Satoh, Shigeru (S); Kagaya, Hideaki (H); Saito, Mitsuru (M); Inoue, Takamitsu (T); Tsuchiya, Norihiko (N); Suzuki, Toshio (T); Habuchi, Tomonori (T);

Affiliation: Department of Pharmacy, Akita University Hospital, Akita, Japan.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: European journal of clinical pharmacology (Eur J Clin Pharmacol), published in Germany. (Language: eng)

Reference: 2009-Oct; vol 65 (issue 10) : pp 1047-53

Dates: Created 2009/09/17; Completed 2009/11/02;

PMID: 19730841, status: MEDLINE (last retrieval date: 11/2/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Enzyme Inhibitors (0) ; Immunosuppressive Agents (0) ; Tacrolimus (109581-93-3) ; Mycophenolic Acid (24280-93-1) ; Prednisolone (50-24-8) ; CYP3A5 protein, human (EC 1.14.14.1) ; Cytochrome P-450 CYP3A (EC 1.14.14.1)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/2000
7/30/2008
Higher Relevance Score (100)
Lower Relevance Score (60)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index